Considerations when using alpha-glucosidase inhibitors in the treatment of type 2 diabetes

Autor:	Stephen N. Davis, Maka S. Hedrington
Rok vydání:	2019
Předmět:	Blood Glucose 1-Deoxynojirimycin medicine.drug_class Type 2 diabetes Pharmacology Prediabetic State 03 medical and health sciences 0302 clinical medicine Diabetes mellitus Humans Hypoglycemic Agents Medicine Upper gastrointestinal Glycoside Hydrolase Inhibitors Pharmacology (medical) Aged Acarbose Alpha-glucosidase inhibitor chemistry.chemical_classification business.industry General Medicine medicine.disease Metformin Enzyme Diabetes Mellitus Type 2 chemistry Cardiovascular Diseases Hyperglycemia 030220 oncology & carcinogenesis business Inositol 030217 neurology & neurosurgery medicine.drug
Zdroj:	Expert Opinion on Pharmacotherapy. 20:2229-2235
ISSN:	1744-7666 1465-6566
DOI:	10.1080/14656566.2019.1672660
Popis:	Introduction: Alpha-glucosidase inhibitors (AGIs) – oral antihyperglycemic drugs, inhibit upper gastrointestinal enzymes that break down complex carbohydrates into glucose. As a result, the absorpt...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bff221e8b6d0fdeedc2a308d9b72edef https://doi.org/10.1080/14656566.2019.1672660 Zobrazit plný text záznamu